Bailey Montgomery
Physician Assistant · Grand Rapids, MINPI 1598526840
Payments from drug & device makers
Across 81 payments — averaging $14.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$200
- E.r. Squibb & Sons, L.L.C.$165
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$151
- Novo Nordisk$91
- Bayer$77
- Kiniksa Pharmaceuticals International, PLC$65
- plus $427 from 14 others
What the payments were for
- Food & beverage$1,176100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 17 | $200 |
| E.r. Squibb & Sons, L.L.C. | 10 | $165 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 21 | $151 |
| Novo Nordisk | 5 | $91 |
| Bayer | 5 | $77 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $65 |
| Merck | 3 | $59 |
| Lexicon Pharmaceuticals, Inc. | 3 | $52 |
| Boehringer Ingelheim | 2 | $38 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| Analog Devices Inc. | 1 | $34 |
| Alnylam Pharmaceuticals Inc. | 1 | $31 |
| Vital Connect, Inc | 1 | $28 |
| Kestra Medical Technology Services, Inc. | 1 | $28 |
| AstraZeneca | 1 | $24 |
| Impulse Dynamics (USA) Inc. | 1 | $21 |
| Pfizer | 1 | $21 |
| Abiomed | 1 | $21 |
| Philips North America LLC | 1 | $17 |
| Scpharmaceuticals Inc. | 1 | $16 |
How this compares
$1,176 in reported general payments places this provider in the 75th percentile of 5,453 physician assistant providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 22 | $28,197 |
| EntrestoSacubitril/Valsartan | 20 | $21,732 |
| BrilintaTicagrelor | 17 | $7,519 |
| Metoprolol Succinate | 70 | $1,460 |
| Ezetimibe | 23 | $1,070 |
| Losartan Potassium | 43 | $646 |
| Rosuvastatin Calcium | 39 | $617 |
| Atorvastatin Calcium | 28 | $531 |
| ClopidogrelClopidogrel Bisulfate | 33 | $514 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 26 | $477 |
| Hydralazine Hcl | 19 | $374 |
| Amlodipine Besylate | 40 | $369 |
| Nitroglycerin | 21 | $314 |
| Lisinopril | 29 | $301 |
| Carvedilol | 16 | $235 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $21 | $28,19722 claims |
| NovartisEntresto | $200 | $21,73220 claims |
| AstraZenecaBrilinta | $24 | $7,51917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in Grand Rapids
- Erin van DykeGrand Rapids$346K
- Melissa JosephGrand Rapids$82K
- Matthew SchultzGrand Rapids$49K
- Shannon ToddGrand Rapids$32K
- Patrick HandlinGrand Rapids$28K
- John MulderGrand Rapids$27K
- Ginger BiesbrockGrand Rapids$25K
- Matthew ZoetemanGrand Rapids$23K
- Aaron ZarnoskyGrand Rapids$22K
- Sarang PatelRoyal Oak$660K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.